Cell Biochemistry and Biophysics

, Volume 49, Issue 1, pp 48–63

Role of Advanced Glycation End Products in Hypertension and Atherosclerosis: Therapeutic Implications

Authors

    • Discipline of Medicine, Faculty of Medicine, Room H-4310, Health Sciences CentreMemorial University of Newfoundland
  • Vicki Gill
    • Discipline of Medicine, Faculty of Medicine, Room H-4310, Health Sciences CentreMemorial University of Newfoundland
  • Pawan Singal
    • Faculty of Medicine, Institute of Cardiovascular SciencesUniversity of Manitoba
Original Paper

DOI: 10.1007/s12013-007-0039-0

Cite this article as:
Vasdev, S., Gill, V. & Singal, P. Cell Biochem Biophys (2007) 49: 48. doi:10.1007/s12013-007-0039-0

Abstract

The vascular diseases, hypertension and atherosclerosis, affect millions of individuals worldwide, and account for a large number of deaths globally. A better understanding of the mechanism of these conditions will lead to more specific and effective therapies. Hypertension and atherosclerosis are both characterized by insulin resistance, and we suggest that this plays a major role in their etiology. The cause of insulin resistance is not known, but may be a result of a combination of genetic and lifestyle factors. In insulin resistance, alterations in glucose and lipid metabolism lead to the production of excess aldehydes including glyoxal and methylglyoxal. These aldehydes react non-enzymatically with free amino and sulfhydryl groups of amino acids of proteins to form stable conjugates called advanced glycation end products (AGEs). AGEs act directly, as well as via receptors to alter the function of many intra- and extracellular proteins including antioxidant and metabolic enzymes, calcium channels, lipoproteins, and transcriptional and structural proteins. This results in endothelial dysfunction, inflammation and oxidative stress. All these changes are characteristic of hypertension and atherosclerosis. Human and animal studies have demonstrated that increased AGEs are also associated with these conditions. A pathological role for AGEs is substantiated by studies showing that therapies that attenuate insulin resistance and/or lower AGEs, are effective in decreasing oxidative stress, lowering blood pressure, and attenuating atherosclerotic vascular changes. These interventions include lipoic acid and other antioxidants, AGE breakers or soluble receptors of AGEs, and aldehyde-binding agents like cysteine. Such therapies may offer alternative specific means to treat hypertension and atherosclerosis. An adjunct therapy may be to implement lifestyle changes such as weight reduction, regular exercise, smoking cessation, and increasing dietary intake of fruits and vegetables that also decrease insulin resistance as well as oxidative stress.

Keywords

Hypertension Atherosclerosis Advanced glycation end products Insulin resistance Oxidative stress Inflammation

Copyright information

© Humana Press Inc. 2007